Pravin Soni

Pravin Soni has more than 30 years of experience developing innovative products, including 20 years in senior management leading the development, manufacture, and registration of novel drug, device, and combination medical products. Prior to Respivant, Dr. Soni was most recently co-founder and CTO of Patara Pharma. Prior to Patara, he was SVP and CTO of Elevation Pharmaceuticals where he was responsible for leading the development of a novel inhalation device/drug combination for the treatment of severe COPD. Prior to Elevation, he was VP of Product Research and Development at Alexza Pharmaceuticals where he led the development of a novel inhalable drug delivery system, the Staccato inhaler, for systemic drug delivery via the deep lung. Prior to Alexza, Dr. Soni was VP of Engineering at Cygnus where he led the development of the first commercial non-invasive, automatic, and continuous blood glucose monitoring system, the GlucoWatch Biographer, as well as a 7-day contraceptive transdermal system that was marketed by Johnson & Johnson as Evra. Dr. Soni graduated with a B.Tech. degree in Chemical Engineering from LIT Nagpur and earned a Ph.D. in Polymer Science and Engineering from Case Western Reserve University.